Healthy adults
Conditions
Interventions
Intake three tablets of test food per day, for eight weeks
Intake three tablets of control food per day, for eight weeks
Sponsors
CPCC Company Limited
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Males and females aged 20 to 64years old when informed consent. (2) Subjects who are cold sensitivity as subjective symptoms. (3) Subjects who receive enough explain of the test, who deeply understanding of the test, and who obtain own consent to participate the test.
Exclusion criteria
Exclusion criteria: (1) Subjects who are diagnosed as cold sensitivity by medical doctor (2) Smokers except who have quitted smoke more than twelve months before the day of consent. (3) Subjects who regularly use blood pressure, blood flow, fatigue and/or cold sensitivity improving medicines, healthy foods (foods for specified health use, functional indication foods) and /or supplements. (4) Females who are pregnant or lactating, and females who could become pregnant or lactating during test period. (5) Subjects who have previous and/or current medical history of serious disease (e.g., heart, liver, kidney, digestive organ). (6) Subjects who excessive alcohol intake. (7) Subjects who have extremely irregular dining habits, and subjects who have midnight work or irregular shift work. (8) Subjects who have previous medical history of drug and/or food allergy. (9) Subjects who have cold allergy. (10) Subjects who prone to diarrhea include who are diagnosed lactose intolerance (11) Subjects who are participating the other clinical tests. Subjects who participated within 4-weeks prior to the current study and/or who plan to participate the other clinical tests. (12) Subjects who donated over 200mL blood and/or blood components within the last one month to the current study. (13) Males who donated over 400mL blood and/or blood components within the last three month to the current study. (14) Females who donated over 400mL blood and/or blood components within the last four month to the current study. (15) Males who will be collected over 1200mL blood and/or blood components, when the sampling amounts within the last twelve month are adding to the planned sampling amounts of this study. (16) Females who will be collected over 800mL blood and/or blood components when, the sampling amounts within the last twelve month are adding to the planned sampling amounts of this study. (17) Others who have been determined ineligible by principal investigator or sub-investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood-flow volume | — |
Secondary
| Measure | Time frame |
|---|---|
| Body surface temperature Acceleration pulse wave Blood NOx level VAS questionnaire Incidence of adverse events and side effects | — |
Countries
Japan
Contacts
Public ContactMasanori Numa
CPCC Company Limited Planning & Sales Department
Outcome results
None listed